Back to results
TerminatedPhase 2

A Feasibility Study of Niraparib for Advanced, BRCA1-like, HER2-negative Breast Cancer Patients

NCT02826512

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Antoni van Leeuwenhoek

Amsterdam, Netherlands

+2 additional locations

View on ClinicalTrials.gov
A Feasibility Study of Niraparib for Advanced, BRCA1-like, HER2-negative Breast Cancer Patients — TrialFind